Eli Lilly to Reveal New Findings on Retatrutide at EASD 2026 | Retatrutide News

Eli Lilly will present new data on Retatrutide and other drugs at EASD 2026. This highlights ongoing research into GLP-1 agonists for cardiometabolic he...
Clinical Trials · November 3, 2026